Skip to content

Clinical trials

Phase 3 Lung Diseases trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Status: Unknown status Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20141
20161
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imam Abdulrahman Bin Faisal University1
Lifesemantics Corp.1
Shanghai Gebaide Biotechnology Co., Ltd.1
The Hospital for Sick Children1
University Hospital, Tours1
University of South Florida1
University of Turin, Italy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases7
Lung Neoplasms3
Respiratory Tract Diseases3
Bronchial Neoplasms2
Carcinoma, Bronchogenic2
Carcinoma, Non-Small-Cell Lung2
Neoplasms2
Thoracic Neoplasms2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Cardiovascular Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.